SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-195042
Filing Date
2021-06-21
Accepted
2021-06-21 16:06:17
Documents
13
Period of Report
2021-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d195177d8k.htm   iXBRL 8-K 27966
2 EX-3.1 d195177dex31.htm EX-3.1 124195
  Complete submission text file 0001193125-21-195042.txt   308311

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zsan-20210617.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20210617_lab.xml EX-101.LAB 18116
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20210617_pre.xml EX-101.PRE 11386
6 EXTRACTED XBRL INSTANCE DOCUMENT d195177d8k_htm.xml XML 3543
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 211030534
SIC: 2834 Pharmaceutical Preparations